| Inflammatory Bowel Disease | Lifetime | 99 | NL 4 | 99.36 |
| Microscopic Colitis | Lifetime | 126 | NL 5 | 99.13 |
| Colorectal Cancer Screening and Detection | Lifetime | 222 | NL 22 | 99.02 |
| Gastric Cancer Management and Outcomes | Lifetime | 462 | NL 28 | 98.98 |
| Genetic factors in colorectal cancer | Lifetime | 489 | NL 27 | 98.26 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 795 | NL 26 | 97.01 |
| Vaccine Coverage and Hesitancy | Lifetime | 571 | NL 16 | 96.47 |
| Autoimmune and Inflammatory Disorders | Lifetime | 224 | NL 5 | 96.69 |
| Diverticular Disease and Complications | Lifetime | 484 | NL 24 | 96.13 |
| Colorectal Cancer Surgical Treatments | Lifetime | 995 | NL 67 | 96.01 |
| Eosinophilic Esophagitis | Lifetime | 964 | NL 26 | 95.81 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 670 | NL 12 | 91.51 |
| Celiac Disease Research and Management | Lifetime | 897 | NL 38 | 91.02 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 537 | NL 20 | 77.56 |
| Inflammatory Bowel Disease | 2021-2025 | 43 | NL 2 | 99.48 |
| Microscopic Colitis | 2021-2025 | 46 | NL 2 | 99.27 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 683 | NL 12 | 97.31 |
| Gastrointestinal disorders and treatments | 2021-2025 | 88 | NL 4 | 96.26 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 119 | NL 1 | 93.89 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 153 | NL 5 | 95.92 |
| Herpesvirus Infections and Treatments | 2021-2025 | 122 | NL 1 | 93.87 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 232 | NL 3 | 94.24 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 474 | NL 9 | 94.10 |
| Hepatitis B Virus Studies | 2021-2025 | 421 | NL 8 | 93.16 |
| Eosinophilic Esophagitis | 2021-2025 | 308 | NL 5 | 93.29 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 712 | NL 11 | 90.44 |
| Gastrointestinal Bleeding Diagnosis and Treatment | 2021-2025 | 246 | NL 1 | 84.72 |
| Diverticular Disease and Complications | 2021-2025 | 660 | NL 44 | 76.67 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 716 | NL 39 | 77.39 |
| Pharmaceutical studies and practices | 2021-2025 | 729 | NL 53 | 77.73 |
| Clinical Nutrition and Gastroenterology | 2021-2025 | 763 | NL 34 | 74.14 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 524 | NL 14 | 70.12 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 631 | NL 4 | 65.17 |
| Intestinal Malrotation and Obstruction Disorders | 2021-2025 | 563 | NL 44 | 63.29 |
| Celiac Disease Research and Management | 2021-2025 | 978 | NL 25 | 61.13 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 585 | NL 12 | 52.67 |
| Stoma care and complications | 2021-2025 | 768 | NL 47 | 52.75 |
